FOREST BASKETT
CIK 1277631 · last filed 2026-03-12
FOREST BASKETT is a corporate insider who has filed 226 SEC Form 4 insider transactions across 69 companies since 2007. The most recent filing shows the insider bought $2.3M of KRRO on Mar 12, 2026. Across all open-market trades the lifetime net is −$842.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $23.23B across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$23.23B
Companies
69
Total Filings
226
Lifetime Open-Market Net
-$842.47M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KRRO | 10%+ Owner | 1,297,893 | $10.50 | $13.63M | $3.30M | 2 | 2026-03-12 |
| SGP | 10%+ Owner | 2,989,408 | $21.62 | $64.63M | $15.00M | 1 | 2026-02-11 |
| NeueHealth, Inc. (BHG) Delisted | Director | 488,702 | $16.35 | $7.99M | $34.99M | 5 | 2025-10-06 |
| BZFDW | 10%+ Owner | 3,674,745 | $0.02 | $86.4K | -$4.21M | 2 | 2025-03-14 |
| NeueHealth, Inc. (NEUE) Delisted | 10%+ Owner | — | $6.75 | — | $0 | 2 | 2024-10-03 |
| MBX | 10%+ Owner | 3,614,486 | $60.06 | $217.09M | $8.00M | 1 | 2024-09-17 |
| SGMT | 10%+ Owner | 3,000,275 | $7.27 | $21.81M | $0 | 1 | 2024-01-31 |
| SVRA | 10%+ Owner | 24,471,264 | $5.33 | $130.43M | $1000.0K | 1 | 2023-07-19 |
| MIRM | 10%+ Owner | 1,548 | $112.23 | $173.7K | $6.75M | 2 | 2023-06-15 |
| COUR | 10%+ Owner | 10,661,886 | $5.85 | $62.37M | $0 | 4 | 2023-02-17 |
| MINERVA SURGICAL INC (UTRS) Delisted | 10%+ Owner | 1,721,853 | $0.00 | $172 | $30.00M | 1 | 2023-02-10 |
| Arcellx, Inc. (ACLX) Delisted | 10%+ Owner | 0 | $115.07 | $0 | -$51.2K | 1 | 2022-12-22 |
| Akouos, Inc. (AKUS) Delisted | 10%+ Owner | 0 | $13.29 | $0 | $10.00M | 2 | 2022-12-02 |
| IONQ.WS | 10%+ Owner | 175,378 | $22.45 | $3.94M | $0 | 1 | 2022-11-18 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | 10%+ Owner | 3,952,957 | $15.00 | $59.29M | $24.62M | 17 | 2022-10-21 |
| GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | 10%+ Owner | 0 | $0.00 | $0 | $21.03M | 4 | 2022-05-26 |
| HOOD | Director | 36,688 | $92.76 | $3.40M | -$29.6K | 5 | 2022-05-04 |
| TRVI | 10%+ Owner | 10,421,428 | $18.43 | $192.07M | $30.00M | 4 | 2022-04-13 |
| IMRA | 10%+ Owner | 872,668 | $14.49 | $12.64M | $54.98M | 3 | 2022-01-11 |
| Metacrine, Inc. (MTCR) Delisted | 10%+ Owner | 3,022,957 | $0.49 | $1.50M | $9.51M | 2 | 2021-12-27 |
| ARDX | 10%+ Owner | 6,207,480 | $5.08 | $31.57M | $80.59M | 10 | 2021-12-27 |
| GLUE | 10%+ Owner | 5,973,296 | $22.04 | $131.65M | $19.95M | 1 | 2021-06-30 |
| Desktop Metal, Inc. (DM) Delisted | 10%+ Owner | 81 | $4.96 | $402 | $0 | 1 | 2021-06-10 |
| Eargo, Inc. (EAR) Delisted | 10%+ Owner | 81 | $2.57 | $208 | $5.60M | 2 | 2021-05-26 |
| MRKR | 10%+ Owner | 1,071,428 | $1.18 | $1.26M | $10.00M | 1 | 2021-03-18 |
| Regulus Therapeutics Inc. (RGLS) Delisted | 10%+ Owner | 645,106 | $8.16 | $5.26M | $3.96M | 3 | 2020-12-07 |
| SPT | 10%+ Owner | 6,065,024 | $8.69 | $52.71M | -$567.90M | 3 | 2020-11-17 |
| NET | 10%+ Owner | 224,970 | $264.10 | $59.41M | -$76.53M | 6 | 2020-11-13 |
| Mersana Therapeutics, Inc. (MRSN) Delisted | 10%+ Owner | 0 | $29.08 | $0 | $14.79M | 4 | 2020-09-16 |
| Inozyme Pharma, Inc. (INZY) Delisted | 10%+ Owner | 2,000,533 | $4.00 | $8.00M | $4.00M | 1 | 2020-07-28 |
| NKTX | 10%+ Owner | 2,902,115 | $2.22 | $6.44M | $12.00M | 1 | 2020-07-16 |
| Adaptimmune Therapeutics PLC (ADAP) Delisted | 10%+ Owner | 82,978,668 | $0.06 | $4.80M | $5.00M | 1 | 2020-01-28 |
| NITE | 10%+ Owner | 0 | $35.77 | $0 | $0 | 1 | 2019-06-07 |
| TESARO, Inc. (TSRO) Delisted | 10%+ Owner | 0 | — | — | $73.04M | 7 | 2019-01-22 |
| ESTC | 10%+ Owner | 655,522 | $62.10 | $40.71M | $0 | 1 | 2018-10-10 |
| ASND | 10%+ Owner | 82,978,668 | $254.44 | $21.11B | $49.02M | 4 | 2018-09-10 |
| Surface Oncology, Inc. (SURF) Delisted | 10%+ Owner | 3,179,544 | $1.07 | $3.40M | $2.00M | 1 | 2018-04-23 |
| Tintri, Inc. (TNTR) Delisted | 10%+ Owner | — | — | — | $0 | 1 | 2018-03-02 |
| Oruka Therapeutics, Inc. (ABIO) Delisted | 10%+ Owner | 0 | $28.80 | $0 | -$731.3K | 1 | 2018-02-27 |
| Cascadian Therapeutics, Inc. (CASC) Delisted | 10%+ Owner | 10,882,574 | — | — | $0 | 1 | 2018-02-22 |
| APPN | 10%+ Owner | 27,242 | $27.35 | $745.1K | -$66.07M | 4 | 2018-02-15 |
| SYNLOGIC, INC. (SYBX) Delisted | 10%+ Owner | 281,929 | $0.69 | $194.5K | $0 | 2 | 2018-01-26 |
| Care.com Inc (CRCM) Delisted | 10%+ Owner | 433 | — | — | $0 | 2 | 2017-11-08 |
| RYTM | 10%+ Owner | 4,909,956 | $108.04 | $530.47M | $9.35M | 1 | 2017-10-10 |
| MULESOFT, INC (MULE) Delisted | 10%+ Owner | 12,679,970 | — | — | $0 | 1 | 2017-03-22 |
| Achaogen, Inc. (AKAO) Delisted | 10%+ Owner | 5,215,128 | — | — | $6.75M | 1 | 2016-12-19 |
| Tableau Software Inc (DATA) Delisted | Director | 10,833 | — | — | -$606.92M | 18 | 2016-12-06 |
| Ra Pharmaceuticals, Inc. (RARX) Delisted | 10%+ Owner | 1,858,450 | — | — | $4.39M | 1 | 2016-10-31 |
| Roka BioScience, Inc. (ROKA) Delisted | 10%+ Owner | 321,681 | — | — | $4.60M | 3 | 2016-09-30 |
| Epizyme, Inc. (EPZM) Delisted | 10%+ Owner | 5,854,351 | $1.47 | $8.61M | $23.85M | 4 | 2016-01-12 |
| SUPN | 10%+ Owner | 71,749 | $47.73 | $3.42M | -$3.71M | 3 | 2015-11-12 |
| Avalo Therapeutics, Inc. (CERC.U) Delisted | 10%+ Owner | 594,245 | — | — | $0 | 1 | 2015-10-20 |
| SYNLOGIC, INC. (MIRN) Delisted | 10%+ Owner | 2,114,375 | — | — | $6.00M | 1 | 2015-10-06 |
| BOX | 10%+ Owner | 2,091,457 | $31.50 | $65.88M | $0 | 1 | 2015-01-29 |
| CVENT INC (CVT) Delisted | 10%+ Owner | 10,000 | $8.52 | $85.2K | -$46.32M | 5 | 2014-11-28 |
| DERM | 10%+ Owner | 3,502,922 | $6.31 | $22.10M | $1.11M | 1 | 2014-10-08 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | 10%+ Owner | 1,376,495 | $18.62 | $25.63M | -$283.8K | 4 | 2014-08-29 |
| Loxo Oncology, Inc. (LOXO) Delisted | 10%+ Owner | 1,789,420 | — | — | $3.00M | 1 | 2014-08-06 |
| AUDIENCE INC (ADNC) Delisted | Director | 0 | — | — | -$1.08M | 8 | 2013-12-04 |
| FUSION-IO, INC. (FIO) Delisted | Director | 7,053,379 | — | — | -$44.16M | 19 | 2013-11-21 |
| XOOM Corp (XOOM) Delisted | 10%+ Owner | 0 | — | — | $0 | 1 | 2013-10-31 |
| GRPN | 10%+ Owner | 2,709,248 | $28.10 | $76.13M | -$331.4K | 2 | 2013-09-17 |
| Clovis Oncology, Inc. (CLVS) Delisted | 10%+ Owner | 494 | $0.08 | $40 | $17.11M | 2 | 2013-06-05 |
| WDAY | 10%+ Owner | 2,321,212 | $159.69 | $370.67M | $0 | 2 | 2013-04-11 |
| Millennial Media Inc. (MM) Delisted | 10%+ Owner | 8,196,614 | — | — | -$21.48M | 2 | 2012-10-30 |
| HYPERION THERAPEUTICS INC (HPTX) Delisted | 10%+ Owner | 1,639,218 | — | — | $5.00M | 1 | 2012-08-02 |
| INNERWORKINGS INC (INWK) Delisted | 10%+ Owner | 15,000 | — | — | -$12.62M | 7 | 2012-03-30 |
| ECHO | 10%+ Owner | 4,000 | $85.93 | $343.7K | $0 | 1 | 2012-03-01 |
| ARYx Therapeutics, Inc. (ARYX) Delisted | 10%+ Owner | 0 | — | — | -$326.3K | 1 | 2011-03-14 |
Recent Filings
226 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-12 | KRRO | Buy (P) | +207,100 | $2.30M | EDGAR |
| 2026-02-11 | SGP | Mixed | +7,392,301 | $15.00M | EDGAR |
| 2025-10-06 | NeueHealth, Inc. (BHG) Delisted | Mixed | −2,280,551 | $10 | EDGAR |
| 2025-03-14 | BZFDW | Sell (S) | −1,814,830 | -$3.99M | EDGAR |
| 2025-03-06 | BZFDW | Sell (S) | −107,655 | -$223.1K | EDGAR |
| 2024-10-03 | NeueHealth, Inc. (NEUE) Delisted | Buy (P) | — | $0 | EDGAR |
| 2024-09-17 | MBX | Mixed | +3,614,486 | $8.00M | EDGAR |
| 2024-04-24 | KRRO | Buy (P) | +17,857 | $1000.0K | EDGAR |
| 2024-04-10 | NeueHealth, Inc. (NEUE) Delisted | Buy (P) | — | $0 | EDGAR |
| 2024-01-31 | SGMT | Other (J) | −838,700 | $0 | EDGAR |
Showing 1–10 of 226
Page 1 of 23
Next
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.